L-DOPA explained

-DOPA, also known as -3,4-dihydroxyphenylalanine and used medically as levodopa, is made and used as part of the normal biology of some plants[1] and animals, including humans. Humans, as well as a portion of the other animals that utilize -DOPA, make it via biosynthesis from the amino acid -tyrosine.

-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, -DOPA itself mediates neurotrophic factor release by the brain and central nervous system.[2] [3] In some plant families (of the order Caryophyllales), -DOPA is the central precursor of a biosynthetic pathway that produces a class of pigments called betalains.[4]

-DOPA can be manufactured and in its pure form is sold as a drug with the levodopa. As a drug, it is used in the treatment of Parkinson's disease and dopamine-responsive dystonia, as well as restless leg syndrome.[5]

-DOPA has a counterpart with opposite chirality, -DOPA. As is true for many molecules, the human body produces only one of these isomers (the -DOPA form). The enantiomeric purity of -DOPA may be analyzed by determination of the optical rotation or by chiral thin-layer chromatography.[6]

Biological role

-DOPA is produced from the amino acid -tyrosine by the enzyme tyrosine hydroxylase. -DOPA can act as an -tyrosine mimetic and be incorporated into proteins by mammalian cells in place of -tyrosine, generating protease-resistant and aggregate-prone proteins in vitro and may contribute to neurotoxicity with chronic -DOPA administration.[7] It is also the precursor for the monoamine or catecholamine neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). Dopamine is formed by the decarboxylation of -DOPA by aromatic -amino acid decarboxylase (AADC).

-DOPA can be directly metabolized by catechol-O-methyl transferase to 3-O-methyldopa, and then further to vanillactic acid. This metabolic pathway is nonexistent in the healthy body, but becomes important after peripheral -DOPA administration in patients with Parkinson's disease or in the rare cases of patients with AADC enzyme deficiency.[8]

-Phenylalanine, -tyrosine, and -DOPA are all precursors to the biological pigment melanin. The enzyme tyrosinase catalyzes the oxidation of -DOPA to the reactive intermediate dopaquinone, which reacts further, eventually leading to melanin oligomers. In addition, tyrosinase can convert tyrosine directly to -DOPA in the presence of a reducing agent such as ascorbic acid.[9]

Chemistry

L-DOPA, also known as L-3,4-dihydroxyphenylalanine or L-3-hydroxytyrosine, is an aromatic amino acid derived from L-phenylalanine and L-tyrosine. It is a phenethylamine, monoamine, and catecholamine, and is a biological precursor of the neurotransmitters dopamine (3,4-dihydroxyphenethylamine), norepinephrine (3,4,β-trihydroxyphenethylamine), and epinephrine (3,4,β-trihydroxy-N-methylphenethylamine).

Synthesis

History

-DOPA was first isolated from the seeds of the Vicia faba (broad bean) plant in 1913 by Swiss biochemist Markus Guggenheim.[10]

The 2001 Nobel Prize in Chemistry was also related to -DOPA: the Nobel Committee awarded one-quarter of the prize to William S. Knowles for his work on chirally catalysed hydrogenation reactions, the most noted example of which was used for the synthesis of -DOPA.[11] [12] [13]

Other organisms

Marine adhesion

-DOPA is a key compound in the formation of marine adhesive proteins, such as those found in mussels.[14] [15] It is believed to be responsible for the water-resistance and rapid curing abilities of these proteins. -DOPA may also be used to prevent surfaces from fouling by bonding antifouling polymers to a susceptible substrate.[16] The versatile chemistry of -DOPA can be exploited in nanotechnology.[17] For example, DOPA-containing self-assembling peptides were found to form functional nanostructures, adhesives and gels.[18] [19] [20] [21]

In plants and in the environment

In plants, L-DOPA functions as an allelochemical which inhibits the growth of certain species, and is produced and secreted by a few legume species such as the broad bean Vicia faba and the velvet bean Mucuna pruriens.[22] Its effect is strongly dependent on the pH and the reactivity of iron in the soil.[23] A 2025 study reported that exogenous L-DOPA triggers a rapid iron-deficiency response in plants, independent of their iron nutritional status.[24] L-DOPA was also suggested to protect Arabidopsis plants against cadmium toxicity.[25]

L-DOPA can also be found in cephalopod ink.[26]

Use as a medication and supplement

See main article: Levodopa.

L-DOPA is used medically under the name levodopa in the treatment of Parkinson's disease and certain other medical conditions. It is usually used in combination with a peripherally selective aromatic L-amino acid decarboxylase (AAAD) inhibitor such as carbidopa or benserazide. These agents increase the strength and duration of levodopa. Combination formulations include levodopa/carbidopa and levodopa/benserazide, as well as levodopa/carbidopa/entacapone.

L-DOPA is found in high amounts in Mucuna pruriens (velvet bean) and is available and used over-the-counter as a supplement.

Notes and References

  1. Cohen PA, Avula B, Katragunta K, Khan I . Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database . JAMA Neurology . 79 . 10 . 1085–1086 . October 2022 . 35939305 . 10.1001/jamaneurol.2022.2184 . 9361182 .
  2. Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS . L-DOPA is an endogenous ligand for OA1 . PLOS Biology . 6 . 9 . e236 . September 2008 . 18828673 . 2553842 . 10.1371/journal.pbio.0060236 . free .
  3. Hiroshima Y, Miyamoto H, Nakamura F, Masukawa D, Yamamoto T, Muraoka H, Kamiya M, Yamashita N, Suzuki T, Matsuzaki S, Endo I, Goshima Y . The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii . British Journal of Pharmacology . 171 . 2 . 403–14 . January 2014 . 24117106 . 3904260 . 10.1111/bph.12459 .
  4. Polturak G, Breitel D, Grossman N, Sarrion-Perdigones A, Weithorn E, Pliner M, Orzaez D, Granell A, Rogachev I, Aharoni A . Elucidation of the first committed step in betalain biosynthesis enables the heterologous engineering of betalain pigments in plants . New Phytol . 210 . 1 . 269–283 . 2016 . 10.1111/nph.13796 . free . 26683006 . 2016NewPh.210..269P . 10251/87415 . free .
  5. Scholz . Hanna . Trenkwalder . Claudia . Kohnen . Ralf . Kriston . Levente . Riemann . Dieter . Hornyak . Magdolna . Levodopa for the treatment of restless legs syndrome . Cochrane Database of Systematic Reviews . 15 February 2011 . 2011 . 5 . CD005504 . 10.1002/14651858.CD005504.pub2 . 21328278 . 196338172 . 8889887 .
  6. Martens J, Günther K, Schickedanz M . Resolution of Optical Isomers by Thin-Layer Chromatography: Enantiomeric Purity of Methyldopa . . 319 . 6 . 572–574 . 1986 . 10.1002/ardp.19863190618 . 97903386 .
  7. Rodgers KJ . Non-protein amino acids and neurodegeneration: the enemy within . Experimental Neurology . 253 . 192–196 . March 2014 . 24374297 . 10.1016/j.expneurol.2013.12.010 . 2288729 .
  8. Hyland K, Clayton PT . Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology . Clinical Chemistry . 38 . 12 . 2405–10 . December 1992 . 1281049 . 10.1093/clinchem/38.12.2405. 16 October 2008 . https://web.archive.org/web/20110607122144/http://www.clinchem.org/cgi/reprint/38/12/2405.pdf . 7 June 2011 . free .
  9. Ito S, Kato T, Shinpo K, Fujita K . Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine . The Biochemical Journal . 222 . 2 . 407–11 . September 1984 . 6433900 . 1144193 . 10.1042/bj2220407 .
  10. Ovallath S, Sulthana B . Levodopa: History and Therapeutic Applications . Annals of Indian Academy of Neurology . 20 . 3 . 185–189 . 2017 . 28904446 . 5586109 . 10.4103/aian.AIAN_241_17 . free .
  11. 10.1021/ar00087a006 . Asymmetric hydrogenation . 1983 . Knowles WS . Accounts of Chemical Research . 16 . 3 . 106–112.
  12. Web site: Synthetic scheme for total synthesis of DOPA, L- (Monsanto) . UW Madison, Department of Chemistry . 30 September 2013.
  13. Knowles WS . Application of organometallic catalysis to the commercial production of L-DOPA. Journal of Chemical Education. March 1986. 63. 3. 222. 10.1021/ed063p222. 1986JChEd..63..222K.
  14. Waite JH, Andersen NH, Jewhurst S, Sun C . Mussel Adhesion: Finding the Tricks Worth Mimicking . J Adhesion . 81 . 2005 . 1–21 . 10.1080/00218460590944602 . 3–4 . 136967853 .
  15. Web site: Study Reveals Details Of Mussels' Tenacious Bonds . Science Daily . 16 August 2006 . 30 September 2013.
  16. Web site: Mussel Adhesive Protein Mimetics . https://web.archive.org/web/20060529181142/http://biomaterials.bme.northwestern.edu/mussel.asp . 29 May 2006 .
  17. Giuri D, Ravarino P, Tomasini C . L-Dopa in small peptides: an amazing functionality to form supramolecular materials . Organic & Biomolecular Chemistry . 19 . 21 . 4622–4636 . June 2021 . 33978030 . 10.1039/D1OB00378J . 234474122 . 11585/840774 . free .
  18. Fichman G, Adler-Abramovich L, Manohar S, Mironi-Harpaz I, Guterman T, Seliktar D, Messersmith PB, Gazit E . Seamless metallic coating and surface adhesion of self-assembled bioinspired nanostructures based on di-(3,4-dihydroxy-L-phenylalanine) peptide motif . ACS Nano . 8 . 7 . 7220–7228 . July 2014 . 24936704 . 4108209 . 10.1021/nn502240r . 2014ACSNa...8.7220F .
  19. Fichman G, Guterman T, Adler-Abramovich L, Gazit E . The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies . Nanomaterials . 4 . 3 . 726–740 . August 2014 . 28344244 . 5304689 . 10.3390/nano4030726 . free .
  20. Fichman G, Andrews C, Patel NL, Schneider JP . Antibacterial Gel Coatings Inspired by the Cryptic Function of a Mussel Byssal Peptide . Advanced Materials . 33 . 40 . October 2021 . 2103677 . 34423482 . 8492546 . 10.1002/adma.202103677 . 2021AdM....3303677F .
  21. Maity S, Nir S, Zada T, Reches M . Self-assembly of a tripeptide into a functional coating that resists fouling . Chemical Communications . 50 . 76 . 11154–11157 . October 2014 . 25110984 . 10.1039/C4CC03578J .
  22. Fujii Y, Shibuya T, Yasuda T. L-3,4-Dihydroxyphenylalanine as an Allelochemical Candidate from Mucuna pruriens (L.) DC. var. utilis . Agricultural and Biological Chemistry . 55 . 2 . 617–618 . 1991 . 10.1080/00021369.1991.10870627 . free .
  23. Hsieh EJ, Liao SW, Chang CY, Tseng CH, Wang SL, Grillet L. L-DOPA induces iron accumulation in roots of Ipomoea aquatica and Arabidopsis thaliana in a pH-dependent manner . Botanical Studies . 64 . 24 . 617–618 . 2023 . 24 . 37620733 . 10449704 . 10.1186/s40529-023-00396-7 . free . 2023BotSt..64...24H .
  24. Hsieh EJ, Rusli MH, Liao SW, Tseng CH, Chang CY, Wang SL, Yang TC, Chan YT, Shih YH, Hong CY, Grillet L. L-DOPA elicits iron deficiency response through root-to-shoot signaling and independently of the canonical regulatory pathway . New Phytologist . 2025 . nph.70823 . 10.1111/nph.70823 . 41408918 .
  25. Chang CY, Hsieh EJ, Wang SL, Grillet L. L-DOPA promotes cadmium tolerance and modulates iron deficiency genes in Arabidopsis thaliana . Physiologia Plantarum . 177 . 2025 . 1 . e70024 . 39727040 . 10.1111/ppl.70024 . 2025PPlan.177E0024C .
  26. Lucero . M. T. . Farrington . H. . Gilly . W. F. . August 1994 . Quantification of L-Dopa and Dopamine in Squid Ink: Implications for Chemoreception . The Biological Bulletin . 187 . 1 . 55–63 . 10.2307/1542165 . 1542165 . 1939-8697 . 29281314 . 1994BiolB.187...55L .